Terms: = Skin cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
6 results:
1. Advancements and perspectives of RBX2 as a molecular hallmark in cancer.
Tao Y; Dai L; Liang W; Li X; Lyu Y; Li J; Li Z; Shi Z; Liang X; Zhou S; Fu X; Hu W; Wang X
Gene; 2024 Jan; 892():147864. PubMed ID: 37820940
[TBL] [Abstract] [Full Text] [Related]
2. staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract] [Full Text] [Related]
3. Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study.
Sun PL; Li B; Ye QF
Int J Colorectal Dis; 2012 Oct; 27(10):1325-32. PubMed ID: 22430888
[TBL] [Abstract] [Full Text] [Related]
4. [Current options and principles of pathomorphology-based tumour diagnostics].
Povýsil C
Vnitr Lek; 2010 Jul; 56(7):709-14. PubMed ID: 20842917
[TBL] [Abstract] [Full Text] [Related]
5. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
[TBL] [Abstract] [Full Text] [Related]
6. Detection of minimal disease in patients with solid tumors.
Pantel K
J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
[TBL] [Abstract] [Full Text] [Related]
